Andres-Hernando, Ana
Li, Nanxing
Cicerchi, Christina
Inaba, Shinichiro
Chen, Wei
Roncal-Jimenez, Carlos
Le, Myphuong T.
Wempe, Michael F.
Milagres, Tamara
Ishimoto, Takuji
Fini, Mehdi
Nakagawa, Takahiko
Johnson, Richard J.
Lanaspa, Miguel A.
Article History
Received: 3 May 2016
Accepted: 7 December 2016
First Online: 13 February 2017
Competing interests
: R.J.J. has grants with Amway and Danone and is on the Scientific Advisory Board of Amway. R.J.J. also has authored two lay books on sugar (fructose) and its role in obesity and metabolic syndrome (The Sugar Fix, Rodale, 2008 and The Fat Switch, mercola.com, 2012). M.A.L., T.I. and R.J.J. have patents and patent application related to the blockade of fructokinase in the prevention and treatment of sugar-induced metabolic syndrome and renal disease. M.A.L., M.T.L., C.R.-J., M.F.W. and R.J.J. are members of Colorado Research Partners, LLC, a company focused on the development of fructokinase inhibitors. All other authors declare no competing financial interests.